Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$828M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$788M |
| 3 |
Qualcomm
QCOM
|
+$771M |
| 4 |
Apple
AAPL
|
+$719M |
| 5 |
Baxter International
BAX
|
+$571M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
Wells Fargo
WFC
|
+$967M |
| 3 |
KKR & Co
KKR
|
+$455M |
| 4 |
Booking.com
BKNG
|
+$401M |
| 5 |
GGP
GGP Inc.
GGP
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.32% |
| 2 | Technology | 13.38% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 9.31% |
| 5 | Consumer Discretionary | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
AB InBev
BUD
$152B
| $414M | 0.1% |
4,729,784
+274,995
| +6% | +$26.8M |
2013 Q2
21 quarters
|
|
202
Emerson Electric
EMR
$90.3B
| $411M | 0.1% |
5,372,611
-94,490
| -2% | -$6.97M |
2013 Q2
21 quarters
|
|
203
Eaton
ETN
$167B
| $411M | 0.1% |
4,737,065
+285,824
| +6% | +$23.4M |
2013 Q2
21 quarters
|
|
204
Energy Transfer Partners
ET
$70.3B
| $411M | 0.1% |
23,558,941
+5,936,099
| +34% | +$105M |
2013 Q2
21 quarters
|
|
205
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.49B
| $406M | 0.1% |
4,856,274
+53,310
| +1% | +$4.45M |
2013 Q2
21 quarters
|
|
206
FedEx
FDX
$69B
| $405M | 0.1% |
1,683,092
+105,736
| +7% | +$25.6M |
2013 Q2
21 quarters
|
|
207
iShares Russell 2000 Value ETF
IWN
$13.9B
| $404M | 0.1% |
3,034,403
-107,157
| -3% | -$14.4M |
2013 Q2
21 quarters
|
|
208
First Trust Value Line Dividend Fund
FVD
$7.68B
| $403M | 0.1% |
12,749,910
+1,457,728
| +13% | +$45.9M |
2013 Q2
21 quarters
|
|
209
Vivmark Residential
VMRK
$47.3B
| $403M | 0.1% |
6,086,929
+901,037
| +17% | +$59.6M |
2013 Q2
21 quarters
|
|
210
Valero Energy
VLO
$125B
| $403M | 0.1% |
3,545,018
+441,925
| +14% | +$50.2M |
2013 Q2
21 quarters
|
|
211
iShare MSCI Eurozone ETF
EZU
$9.24B
| $400M | 0.1% |
9,746,763
-1,356,638
| -12% | -$56.3M |
2013 Q2
21 quarters
|
|
212
Intuit
INTU
$80.9B
| $398M | 0.1% |
1,751,277
-872,611
| -33% | -$187M |
2013 Q2
21 quarters
|
|
213
DELISTED
Praxair Inc
PX
| $398M | 0.1% |
2,474,261
+275,569
| +13% | +$44.3M |
2013 Q2
21 quarters
|
|
214
First Trust North American Energy Infrastructure Fund
EMLP
$4.05B
| $389M | 0.1% |
16,591,160
-222,811
| -1% | -$5.32M |
2013 Q2
21 quarters
|
|
215
Phillips 66
PSX
$111B
| $388M | 0.1% |
3,445,696
+100,046
| +3% | +$11.6M |
2013 Q2
21 quarters
|
|
216
iShares S&P Small-Cap 600 Growth ETF
IJT
$7.73B
| $385M | 0.1% |
3,819,994
-52,614
| -1% | -$5.29M |
2013 Q2
21 quarters
|
|
217
BP
BP
$119B
| $384M | 0.1% |
8,714,973
+65,056
| +0.8% | +$2.72M |
2013 Q2
21 quarters
|
|
218
Boston Properties
BXP
$9.43B
| $380M | 0.1% |
3,089,283
-141,434
| -4% | -$18M |
2013 Q2
21 quarters
|
|
219
Northrop Grumman
NOC
$68.3B
| $379M | 0.09% |
1,194,852
+148,921
| +14% | +$45.4M |
2013 Q2
21 quarters
|
|
220
TJX Companies
TJX
$153B
| $379M | 0.09% |
6,760,348
+448,878
| +7% | +$23.1M |
2013 Q2
21 quarters
|
|
221
HealthEquity
HQY
$7.66B
| $378M | 0.09% |
4,001,425
+536,366
| +15% | +$46.2M |
2014 Q3
16 quarters
|
|
222
State Street SPDR S&P Dividend ETF
SDY
$20.7B
| $377M | 0.09% |
3,853,595
+101,324
| +3% | +$9.82M |
2013 Q2
21 quarters
|
|
223
EOG Resources
EOG
$77.7B
| $376M | 0.09% |
2,948,229
-499,142
| -14% | -$60.7M |
2013 Q2
21 quarters
|
|
224
Vanguard High Dividend Yield ETF
VYM
$80.5B
| $368M | 0.09% |
4,220,473
+86,614
| +2% | +$7.49M |
2013 Q2
21 quarters
|
|
225
Kinder Morgan
KMI
$72.3B
| $366M | 0.09% |
20,662,845
+2,756,160
| +15% | +$49.3M |
2013 Q2
21 quarters
|
|
Similar funds
Morgan Stanley's Q3 2018 Portfolio in Review
As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,205 reduced and 166 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
- Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
- Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
- Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
- Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
- Morgan Stanley opened 207 new positions and closed 166 in Q3 2018.
- Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.